Stay updated on ONC201 + Nivolumab in MSS mCRC Clinical Trial
Sign up to get notified when there's something new on the ONC201 + Nivolumab in MSS mCRC Clinical Trial page.

Latest updates to the ONC201 + Nivolumab in MSS mCRC Clinical Trial page
- Check2 days agoChange DetectedLocations now includes Rhode Island and the page revision is updated to v3.3.3; the separate 'Rhode Island Locations' entry and the HHS Vulnerability Disclosure link appear to have been removed.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision label updated from Revision: v3.2.0 to Revision: v3.3.2, indicating a minor update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedNotice about government funding lapse and potential operating status updates was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check52 days agoChange DetectedThe two screenshots show the same study page with minor visual differences only, and there are no changes to core trial details such as enrollment, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check80 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.SummaryDifference3%

- Check87 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to ONC201 + Nivolumab in MSS mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONC201 + Nivolumab in MSS mCRC Clinical Trial page.